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Summary  
The pathogenesis of calcium pyrophosphate dihydrate (CPPD) crystal deposition disease of synovial joints is still 
unclear, although overproduction f extracellular pyrophosphate (PPi) is thought o play a key role. We studied the 
light and electron microscopic appearances of a case of CPPD crystal deposition disease of the temporomandibular 
joint (TMJ) in search of new clues for its pathogenesis. Light microscopic examination of CPPD-containing material 
from the joint space revealed cartilaginous nodules with various degrees of crystallization. Transmission electron 
microscopic examination revealed numerous extra- as well as intracellular crystals and crystal shaped spaces in the 
chondrocytes. Other striking ultrastructural features of the chondrocytes included the presence of many mitochondria, 
frequently containing crystalline material, and the presence of highly dilated rough endoplasmic reticulum and large 
glycogen islands. The presence of intramitochondrial crystals may hypothetically imply a derangement i  mitochon- 
drial adenosine triphosphate orPPi metabolism. The finding of intracellular CPPD crystals in chondrocytes points to 
the existence of an intracellular pathway of CPPD crystal formation in CPPD crystal deposition disease of the TMJ 
and possibly in CPPD crystal deposition disease in general. 
Key words: Calcium pyrophosphate dihydrate crystal deposition disease, Temporomandibular joint, Pathogenesis, 
Intracellular crystal formation. 
I n t roduct ion  
CALCIUM pyrophosphate dihydrate (CPPD) crystal 
deposition disease is characterized by the presence 
of CPPD crystals in intra-articular and to a lesser 
extent peri-articular tissues. CPPD crystals are 
predominantly found in articular cartilage and 
meniscus, but also in synovial membrane, joint 
capsules, tendons, ligaments and blood vessels 
[1, 2]. CPPD crystals appear to have a preference 
for fibrocartilage rather than hyaline cartilage. In 
fibrocartilage the crystal deposits are diffusely 
distributed. In hyaline cartilage the crystal de- 
posits are found in the midzonal or superficial 
areas, arranged in well-outlined, various-sized 
crystal aggregates [1, 3, 4]. The cartilage matrix 
may show several degenerative changes, including 
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collagen fibril fragmentation, fibrillation and re- 
duced proteoglycan content, whereas the number 
of chondrocytes may be reduced [4, 5]. In areas of 
initial formation of CPPD crystals, hypertrophic 
chondrocytes have been shown to contain abhor- 
mally abundant intracellular proteoglycans [6, 7]. 
Chondrocytes, at the ultrastructural level, may 
show several other degenerative changes, includ- 
ing poorly identifiable mitochondria nd Golgi 
cpmplexes,~intracytoplasmic lipid droplets, large 
glycogen islands, and disrupted cell membranes 
[8-121. 
The pathogenesis of CPPD crystal deposition 
disease is still unclear. CPPD crystal formation 
may result from the presence or exposure of nucle- 
ating agents, the absence or removal of inhibitors, 
elevations in the concentrations of precipitating 
ions (calcium and inorganic pyrophosphate (PPi)), 
or from combinations of these factors [13]. 
Crystal nucleation may be predisposed to by 
matrix changes such as collagen fibril fragmen- 
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tation and changed content and composition of 
glycosaminoglycans of proteoglycans [4, 5]. This 
may also explain the frequent finding of crystals 
in 0steoarthritic joints, in which similar matrix 
changes are found [14]. The effect of removal of 
inhibitors is i l lustrated in aging hyaline articular 
cartilage, in which CPPD crystal deposition is 
facilitated due to an increased keratan sulfate/ 
chondroitin sulfate ratio, keratan sulfate being a 
less potent inhibitor of CPPD formation than 
chondroitin sulfate [15]. 
The role of calcium in CPPD crystal deposition 
disease has received relatively little attention. 
However, several diseases resulting in hypercal- 
cemia have been associated with CPPD crys ta l  
deposition disease [1]. 
The role of PPi in CPPD crystal deposition 
disease has been the focus of much research. Intra- 
cellular PPi is produced in many reactions, includ- 
ing the biosynthesis of macromolecules, various 
metabolic activations, and the direct hydrolysis of 
nucleotide triphosphates. The major biological 
source of PPi is probably the pyrophosphorylysis of 
nucleotide triphosphates during biosynthesis of 
both cell constituents and of matrix destined mol- 
ecules [16, 17]. In normal cells, PPi in the cytosol, 
which is the soluble part of the cytoplasm, is 
further hydrolysed to orthophosphate by neutral 
inorganic pyrophosphatases. In chondrocytes from 
chondrocalcinotic cartilage, however, signifi- 
cantly higher intracellular PPi levels have been 
found than in chondrocytes from normal or osteo- 
arthritic cartilage [18]. The concentration of syn- 
ovial fluid PPi is raised in patients with CPPD 
crystal deposition disease [13, 16, 19]. However, the 
concentration of plasma PPi is similar to normal 
control subjects, implying a local origin of syn- 
ovial fluid PPi [1]. The chondrocytes were assumed 
to be the source of the raised concentration of 
synovial fluid PPi, because CPPD crystals are first 
seen adjacent o these cells. This assumption was 
subsequently supported by in vitro studies, in 
which articular cartilage was shown to produce 
extracellular PPi, whereas ynovium, subchondral 
bone and nonarticular cartilage did not [20-22]. 
Transforming rowth factor fl 1 (TGF fl 1) has been 
shown to stimulate extracellular PPi production 
[22], insulin-like growth factor 1 (IGF-1) inhibits 
this effect [23]. Extracts of cartilage of patients 
with CPPD crystal deposition disease generated 
more extracellular PPi from added adenosine 
triphosphate (ATP) than extracts of cartilage of 
patients with osteoarthritis or control subjects 
[24]. Because PPi probably cannot pass cell mem- 
branes, and crystal formation has been seen extra- 
cellularly, subsequent research has focussed on 
extracellular PPi-generating activities of chondro- 
cytes, such as ecto-enzymes, cell leakage of PPi or 
suitable substrate for these ecto-enzymes, and co- 
production and release with synthetic products 
[16, 17, 25, 26]. An ecto-enzyme, nucleotide triphos- 
phate pyrophosphohydrolase (NTPPPH), has been 
identified in cultures of normal canine cartilage 
that generated PPi from added ATP [25]. NTPPPH 
is found both in cell membranes and in matrix 
vesicles [27, 28]. Synovial fluid levels of both 
NTPPPH and ATP, a potential substrate for 
NTPPPH, are raised in patients with CPPD crystal 
deposition disease [19, 26, 29]. Articular cartilage 
vesicles, resembling matrix vesicles, have been 
shown to be capable of generating CPPD crystals 
from added ATP in vitro [28, 30]. Articular carti- 
lage has been shown to mineralize in the presence 
of ATP in a manner similar to that found with 
articular cartilage vesicles. Consequently, articu- 
lar cartilage vesicles have been attributed a role in 
both CPPD and basic calcium phosphate crystal 
deposition [27]. 
To explore the possibility of co-production and 
release of PPi with synthetic produc~s as an extra- 
cellular PPi-generating activity, PPi-producing 
bi0syntheses prominent in or peculiar to chondro- 
cytes, which occur in cell compartments i olated 
from the pyrophosphatases in the cytosol, were 
studied. Because hypertrophic hondrocytes have 
been demonstrated to contain abundant intra- 
cellular proteoglycans [7], biosynthesis of sulfated 
glycosaminoglycans, which comprise a major com- 
portent of proteoglycans, was studied. However, 
sulfated glycosaminoglycan synthesis, occurring 
in the Golgi complex and producing PPi, has been 
shown to be dissociated of extracellular PPi elabor- 
ation in vitro [31]. Nevertheless, further study is 
needed of PPi-producing biosyntheses of other 
macromolecules, e.g. type I collagen, which has 
also been demonstrated to be present in hyper- 
trophic chondrocytes [32]. 
Although much research has been done, the 
pathogenesis of CPPD crystal deposition disease 
has still not been elucidated. The aim of this study 
was to study the light and electron microscopic 
appearances of a case of CPPD crystal deposition 
disease of the temporomandibular joint, in search 
of new clues for its pathogenesis. 
Case report 
A 53-year-old Caucasian woman was referred to 
the Department of Oral and Maxillofaeial Surgery, 
University Hospital of Groningen, for diagnosis 
and treatment of persistent pain in her left tem- 
poromandibular joint (TMJ). After an initial 
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period of occasional clicking, the patient 
also suffered from joint locking. Physical examin- 
ation showed "tenderness of the left TMJ, 
slightly limited translation of the left mandibular 
condyle, and minor deviation of the mandible to 
the left side during mouth opening. Radiographic 
examination showed only slight degenerative 
changes of the left TMJ. Magnetic resonance imag- 
ing (MRI) showed an anterior articular disc pos- 
ition in the left TMJ in both the open and the 
closed mouth position. Based on clinical, radio- 
graphic and MRI findings, a diagnosis was made of 
anterior disc displacement without reduction 
and capsulitis. Treatment consisted of physical 
therapy. However, over the next year, the patient 
suffered several attacks of acute arthritis of the 
left TMJ, which were characterized by severe 
pain, pre-auricular swelling, limited mouth open- 
ing, and malocclusion. Sometimes the knees, the 
left elbow and the right proximal interphalangeal 
joints were also swollen. Radiographic examin- 
ation of the left TMJ, 9 months after her first 
consultation, revealed extensive lysis of the 
mandibular condyle and the articular eminence. 
Radiographic examination of the knees, arms and 
hands revealed no abnormalities. Computed tom- 
ography (CT) of the left TMJ, performed to exclude 
tumor formation, revealed a considerable amount 
of calcified material in the joint space (Fig. 1). The 
differential diagnosis included synovial osteo- 
chondromatosis and a crystal deposition disease. A
condylectomy, synovectomy and joint debridement 
were planned. 
During surgery the entire joint space of the left 
TMJ appeared to be filled with granulomatous 
tissue, containing numerous nodules. These nod- 
ules varied in size, and felt firm and granular. The 
nodular granulomatous ti sue was attached to the 
joint surfaces, as well as lying free in the joint 
space. Most of this tissue was lying anterior to the 
condyle. Underneath the attached nodular granu- 
lomatous tissue at the articular surfaces, resorp- 
tion cavities in the condyle and eminence appeared 
to contain the same nodular material as was seen 
encapsulated in the granulomatous ti sue. Smooth, 
normal looking articular cartilage was hardly 
available at the articular surfaces. Remnants of 
the articular disc were found anteromedial to the 
condyle. An extensive joint debridement and 
condylar shave were performed. Post-operatively 
the patient reported a significant decrease in pain, 
whereas joint mobility had increased. 
The dissected nodular granulomatous ti sue was 
transferred immediately into a fixative, containing 
2% paraformaldehyde and 0.5% glutaraldehyde in 
a 0.1 M phosphate buffer (pH 7.4). After a fixation 
period of several weeks, one part of the tissue was 
processed for light microscopic (LM) examination, 
one part was processed for transmission electron 
microscopic (TEM) examination and energy disper- 
sive X-ray analysis (EDAX), and one part was used 
for X-ray diffraction analysis of the calcified por- 
FIG. 1. (a) Axial CT scan. A considerable amount of calcified material (arrows) is present around the left mandibular 
condyle (C). (b) Sagittal CT scan of the left TMJ. A considerable amount of calcified material is situated anterior to 
the mandibular condyle, a smaller amount posterior to the condyle. Both the upper and lower joint space seem to be 
affected. Note the irregularities of the articular surfaces (arrows). 
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tion of the dissected tissue. The LM specimens 
were dehydrated in a graded series of ethanol and 
embedded in paraffin. Sections 7~m thick were 
cut on a rotation microtome and stained with 
hematoxytin & eosin or toluidine blue. 
The TEM specimens were post-fixed in a 1°//o 
osmium tetroxide solution, dehydrated in a graded 
series of ethanol and propylene oxide, and embed- 
ded in Polybed 812 (PolyScience Inc., Warrington, 
Pennsylvania, USA). Semi-thin sections I ttm thick 
were cut with a glass knife on a Reichert OMU4 
ultratome (Reichert Scientific Instruments, Wien, 
Austria) and stained with toluidine blue for orien- 
tation and identification of the areas of interest. 
Subsequently, ultrathin sections 40-60 nm thick 
were cut with a diamond knife and mounted on 
copper grids. The sections were stained with 
uranyl acetate and lead citrate. 
LM examination of the sections revealed many 
cartilaginous nodules encapsulated by dense 
fibrous tissue (Fig. 2). The cartilaginous nodules 
varied in size, and showed various amounts of 
crystals within the cartilage matrix. The degree of 
crystal formation varied from initial crystal for- 
mation in areas where many (clusters of) chondro- 
cytes and small crystal deposits in the cartilage 
matrix were seen (Fig. 3), to extensive crystal 
formation in areas where the entire cartilage 
matrix was packed with crystals and only few 
(remnants) of chondrocytes were seen. Intracellu- 
lar crystals could frequently be seen in the chon- 
drocytes (Fig. 4). At the periphery of the crystal 
deposits, multinucleated giant cells with intra- 
cellular crystals were occasionally seen (Fig. 5). 
The encapsulating fibrous tissue contained abun- 
dant collagen and had a cellular-rich appearance. 
Blood vessels were occasionally seen. An inflam- 
matory infiltrate was absent. Characteristics of 
synovial membrane were not seen. 
TEM examination revealed chondrocytes mbed- 
ded in a fibrous matrix with numerous extra- as 
well as intracellular empty spaces from which 
crystals had been dislodged during processing 
(Fig. 6). Clustering of chondrocytes was frequently 
seen. Occasionally, nucleoli, indicating an in- 
crease in protein synthesis [33], were found. A 
nuclear fibrous lamina was often seen between the 
inner membrane of the nuclear envelope and the 
marginal condensates of heterochromatin. 
Mitochondria were numerous in the chondro- 
cytes, and were often seen in the vicinity of in- 
tracellular crystal shaped spaces (Figs 7-12). These 
mitochondria often had poorly defined cristae and 
contained amorphous, granular material of 
medium electron-density (Fig. 7). Frequently, elec- 
tron-dense structures were seen in often hyper- 
trophic mitochondria, suggestive of early CPPD 
crystal formation (Figs 8, 10 & 11). The more 
crystal shaped spaces were present in the ch0ndro- 
cytes, the more poorly defined were the mitochon- 
drial cristae and the more electron-dense 
structures appeared inside the mitochondria. 
Especially in chondrocytes packed with crystal 
shaped spaces, degenerated mitochondria appeared 
to be filled with crystalline material from which 
parts had been dislodged or with only remnants of 
electron-dense crystalline material (Fig. 12). 
The rough endoplasmic reticulum (RER) of 
the chondrocytes was usually well-developed, 
although often showing signs of disorganization. 
In most chondrocytes with intracellular crystal 
shaped spaces, the cisternae were quite dilated and 
contained granular material, indicating storage of 
proteinaceous secretory products [33] (Figs 9 & 12). 
Occasionally the characteristic ~ibosome lining of 
the cisternae was lost, the so-call~d egranulation 
of the RER, probably resulting in impaired protein 
synthesis [33] [Fig. 12(b)]. The Golgi~ complex was 
well-developed in most chondrocytes, with intra- 
cellular crystal shaped spaces and many Golgi- 
derived vesicles were seen. Few eleCtron-dense 
lysosome-like bodies and lipid droplets were found. 
Intracytoplasmic filaments were numerous, es- 
pecially in chondrocytes with intracellula~ crystal 
shaped spaces (Fig. 12). The presence of a nuclear 
fibrous lamina, lipid droplets and intracytoplasmic 
filaments can be considered as nonspecific ultra- 
structural characteristics of affected chondrocytes 
[33]. Large amounts of electron-dense glycogen 
particles, indicating a decreased metabolic activity 
[33], were seen (Fig. 9). Glycogen was usually found 
in chondrocytes with many intracellular crystal 
shaped spaces, although in some cells that were 
packed with these spaces only few glycogen par- 
ticles could be seen. Micropinocytotic vesicles, 
indicating endocytotic activity [33], were fre- 
quently seen. Disrupted cell membranes, indicat- 
ing cell necrosis, were only rarely seen.  
A territorial matrix around the chondrocytes 
often could not be discerned. The matrix was 
fibrous, containing fine filaments. Matrix vesicles 
were not seen. 
Crystals were found both in chondrocytes a well 
as in the cartilage matrix (Figs 13 & 14). The 
crystals varied considerably in size (¢ 0.06-0.3 #m), 
and were rod-shaped or rhomboidal in shape. Crys- 
tal fractures were frequently seen. Occasionally a 
foamy appearance due to sublimation by the elec- 
tron beam was noted. EDAX of both intra- and 
extracellular crystals in nonosmicated unstained 
sections showed calcium and phosphorous peaks 
(Fig. 15). The calcium:phosphorus ratio was 
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FIG. 2. LM section of nodular granulomatous tissue. Various-sized cartilaginous nodules (CN), containing many 
crystals, are encapsulated by dense fibrous tissue (FT). Polarized light. (7#m section. Toluidine blue stain. 
Magnification × 16.) 
FIG. 3. LM section of cartilaginous nodule with initial crystal formation, showing many clusters of chondrocytes and 
small crystal deposits in the cartilage matrix. Transmitted light. (7 #m section. Toluidine blue stain. Magnification 
× 64.) 
FIG. 4. LM section of cartilaginous nodule with intermediate crystal formation, showing many irregularly shaped 
chondrocytes with intracellular crystals (arrows). Polarized light. (1 pm section. Toluidine blue stain. Magnification 
x 128.) 
FIG. 5. LM section of cartilaginous nodule with intermediate crystal formation, showing multinucleated giant cells at 
the periphery of the nodule with intracellular crystals (arrows). Polarized light. (1 pm section. Toluidine blue stain. 
Magnification × 64.) 
1:0.84+0.05 (N=4) ,  which is close to the cal- 
cium:phosphorus ratio of CPPD. X-ray diffraction 
identified the crystals as calcium pyrophosphate 
dihydrate, permitting a definitive diagnosis of 
CPPD crystal deposition disease to be made. 
In patients with CPPD crystal deposition 
disease with early onset of arthrit is (under 55 years 
of age), usually with acute attacks, involving sev- 
eral joints, predisposing metabolic conditions 
should be suspected [34,35]. In this patient, 
laboratory screening (including routine hemato- 
logical studies~ serum values of calcium, 
phosphate, alkaline phosphatase, uric acid, 
magnesium, ferritin, and liver and thyroid func- 
tions) did not reveal any predisposing metabolic 
condition. 
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FIG. 6. Electron micrograph of two chondrocytes mbedded in fibrous matrix with numerous crystal shaped spaces (C). 
Note several intracellular crystal shaped spaces (arrows). (Magnification × 4076.) 
FIG. 7. Electron micrograph of several mitochondria with poorly defined mitochondrial cristae. (Magnification 
× 71 020.) 
FIG. 8. Electron micrograph of mitochondria containing electron-dense tructures, uggestive of early CPPD crystal 
formation. (Magnification × 71 020.) 
Discuss ion  
Numerous intracellular CPPD crystals and 
crystal shaped spaces have been found in the 
chondrocytes in this study of CPPD crystal depo- 
sition disease of the TMJ. To the best of our 
knowledge, this is the first study demonstrating 
intracellular CPPD crystals, especially in 
such strikingly large amounts. Occasional intra- 
cellular crystals in chondrocytes have been re- 
ported before [36,37], but these have been 
discarded as been phagocytosed [1]. In our opinion 
the numerous intracellular crystals found in 
this study have been formed intracellularly, be- 
cause chondrocytes only have limited phagocytic 
potential. Moreover, the crystals in this study were 
lying free in the cytoplasm and inside the mito- 
chondria, but not in phagosomes as is seen in 
synovial lining cells with phagocytosed crystals 
[38, 39]. Further, microscopic evidence of phago- 
cytosis by chondrocytes of CPPD crystals has not 
been found in this study nor in any other micro- 
scopic study. 
In normal cells intracellular and intramitochon- 
drial CPPD formation is militated against by the 
presence of inorganic pyrophosphatases in the 
cytosol and, to a lesser extent, in the mitochondrial 
matrix [40]. Mitochondrial inorganic pyrophos- 
phatase is needed for the preservation ofmitochon- 
drial DNA and protein synthesis [41]. In this study, 
electron-dense crystalline material suggestive of 
initial CPPD formation has been found in mito- 
chondria of chondrocytes. Unfortunately, this 
crystalline material could not be analyzed by 
EDAX because of the small size and the difficulty 
of distinguishing cell structures in nonosmicated 
unstained sections required for EDAX. However, 
mitochondrial crystal formation has been reported 
earlier, e.g. in osteogenesis imperfecta nd in calci- 
fying pulp tissue, although in these cases hydroxy- 
apatite was deposited [42,43]. In mitochondria, 
several major metabolic reactions are carried out 
in the generation of ATP, including the conversion 
of pyruvate into acetyl CoA, the citric acid cycle, 
the oxidative phosphorylation, and the fatty acid 
oxidation [44]. Fatty acids are, prior to entry in the 
mitochondrial matrix, activated on the mitochon- 
drial membrane through reaction with ATP, 
Osteoarthrit is and Cartilage Vol. 3 No. 1 41 
FIG. 9. Electron micrograph of chondrocyte with several intracellular crystal shaped spaces (C). Note remnants of 
dislodged crystals (arrow), nuclear fibrous lamina (arrowhead), mitochondria (M) with poorly defined cristae 
containing ranular material, dilated rough endoplasmic reticulum (RER), few lipid droplets (L), large amounts of 
glycogen particles (GP), and many pinocytotic vesicles (PV). (Magnification x28 408.) 
FIc. 10. Electron micrograph of hypertrophic mitochondrion containing electron-dense structures, uggestive of early 
CPPD crystal formation. (Magnification z 71020.) 
Fro. 11. Electron micrograph of mitochondria containing partially dislodged electron-dense structures, uggestive of 
CPPD crystal formation. (Magnification x71020.) 
releasing PPi [44]. Moreover, although PPi prob- 
ably cannot passively pass cell membranes, the 
mitochondrial membrane has an active transport 
system for PPi [45]. Further, at least in heart 
muscle cells, PPi is capable of stimulating release 
of calcium from mitochondrial stores [45]. Con- 
sequently, the presence of CPPD crystals in 
mitochondria may imply a derangement in mito- 
chondrial ATP or PPi metabolism, resulting in 
high intramitochondrial PPi levels. 
Ishikawa et al. [7] and Ohira and Ishikawa 
[46] demonstrated the presence of electron-dense 
amorphous material in hypertrophic chondrocytes 
and, through leakage from disrupted cell mem- 
branes, in the extracellular matrix. A high PPi 
concentration was suggested to be present in 
this electron-dense amorphous material, which 
contained proteoglycans and debris of cellular 
components [7]. It is conceivable that the 
electron-dense amorphous material demonstrated 
by Ishikawa and Ohira, which resembles the 
electron-dense material found in mitochondria in 
this study, contains (contents of) degenerated 
mitochondria. 
Besides intramitochondrial PPi, intramitochon- 
drial calcium is needed for intramitochondrial 
CPPD formation. Intracellular accumulation of 
calcium has been demonstrated in hypertrophic 
chondrocytes surrounding CPPD crystals. Calcium 
was located especially within electron-dense amor- 
phous material and on the margins of intracellular 
li~]cl droplets [46]. No evidence of calcium was 
found in mitochondria: however, this was reported 
of hypertrophic hondrocytes not surrounding 
CPPD crystals. 
In mammalian mitochondria n general, calcium 
inhibits inorganic pyrophosphatase through bind- 
ing with th~ substrate PPi. At least in yeast mito- 
chondria, it is suggested that calcium has a 
physiologic role in the metabolic ontrol of mito- 
chondria [41]. If calcium has a similar role in 
mitochondria in chondrocytes, the presence of 
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intramitochondrial CPPD crystals may be an 
additional indication o fa  deranged mitochondrial 
metabolism in CPPD crystal deposition disease. 
An excessive increase in intracellular calcium 
will result in cell necrosis. It might be argued that 
the intracellular CPPD crystals found in this study 
were formed after cell degeneration and sub- 
sequent cell necrosis had occurred. However, most 
chondrocytes containing CPPD crystals had elec- 
tron microscopic haracteristics of cell vitality and 
cell activity, including well-developed Golgi com- 
plexes and micropinocytotic vesicles, whereas dis- 
rupted cell membranes were only rarely seen. 
Elevated levels of PPi and calcium are not the 
single most important determinants in CPPD for- 
mation; other factors stimulating or inhibiting 
crystal nucleation, growth and dissolution should 
also be considered [19]. In general, the solubility 
product of calcium and PPi favors nucleation of 
CPPD crystals under selective conditions, prefer- 
entially in gels [47, 48]. In model systems, native 
type I collagen fibers can nucleate CPPD crystal 
formation [49]. This may explain the preference of 
CPPD crystal deposition disease for fibrocartilage 
such as TMJ articular cartilage, which predomi- 
nantly contains type I collagen [50]. In contrast, in 
a TEM study of CPPD crystal deposits in patient 
material Pritzker found no association with colla- 
gen [12]. The majority of CPPD deposits found had 
replaced the chondrocyte and adjacent pericellular 
matrix, and obliterated the chondrocytes, in our 
opinion possibly suggesting intracellular crystal 
deposition whether before or after cell necrosis and 
cell membrane disruption. If the possibility of 
intracellular CPPD formation is confirmed, further 
research is needed of factors stimulating and 
inhibiting intracellular CPPD nucleation. 
Finally, considering the heterogeneous clinical 
character of CPPD crystal deposition disease, var- 
ious pathogenic pathways may exist in various 
patients with CPPD crystal deposition disease, 
with different predominating factors stimulating 
or inhibiting crystal formation. In our opinion the 
finding of intracellular CPPD crystals in this study 
points to the existence of an intraceli~alar pathway 
of CPPD crystal formation. 
FIG. 12. (a) Electron micrograph of chondrocyte packed with crystal shaped spaces (C). Note the presence of many 
mitochondria (M), dilated rough endoplasmic reticulum (RER), numerous intracytoplasmic filaments, and many short 
cell processes (arrows). (Magnification x20 736.). (b) Detail of other part of chondrocyte shown in (a), showing both 
holes and remnants of dislodged crystalline material (arrows) in mitochondria. Note lost ribosome lining (arrowheads) 
of dilated RER, (Magnification x31 081.) (c) Detail of other part of chondrocyte shown in (a), showing crystalline 
material, from which parts have been dislodged (arrows), in mitochondria. (Magnification x31 081.) 
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FIG. 13. Electron micrograph of chondrocyte with intracellular crystals lying free in the cytoplasm. (Magnification 
× 130 643.) 
FIG. 14. Electron micrograph of cartilage matrix packed with crystals. (Magnification × 7142.) 
The cartilaginous nodules examined in this 
study have been dissected from the joint space, 
where they were encapsulated by granulomatous 
tissue. In most studies of CPPD crystal deposition 
disease, biopsies were taken directly frdm the car- 
tilage. Nevertheless, in our opinion, the cartilagi- 
nous fragments examined in this study originally 
derived from the articular cartilage, as evidenced 
by the presence of the same nodular material on 
the surfaces of the condyle and articular eminence 
as was seen encapsulated by the granulomatous 
Fro. 15. X-ray energy spectrum, showing calcium and 
phosphorous peaks. P = phosphorus, C1 = chlorine, 
Ca = calcium. 
tissue. Probably, CPPD crystals were initially de- 
posited in the articular cartilage of the condyle 
and articular eminence. Due to loss of carti lage 
integrity and to subsequently reduced surface 
smoothness and cartilage compliance [51], carti- 
lage fractures might have occurred and cartilage 
fragments might have become liberated into the 
joint space, where they were encapsulated by pro- 
liferating synovial tissue. Articular disc tissue 
might also be involved in this process. Since CPPD 
crystal deposition disease has a preference for 
fibrocartilage rather than hyaline cartilage, this 
may explain the large tumor-like amounts of cal- 
cified tissue found in CPPD crystal deposition 
disease of the TMJ in this and other studies 
[52-60]. Unfortunately, disc tissue could not be 
discerned in this study because, due to the severe 
degeneration, remnants of disc tissue were hardly 
distinguishable from the nodular granulomatous 
tissue. 
The intracellular CPPD crystals in chondrocytes 
descri.bed in this study and the consequent discus- 
sion are based on the findings in TMJ fibrocartilag- 
inous material from only one patient. Because 
CPPD crystal deposition disease of the TMJ is very 
rare, it is unrealistic to wait for studies of larger 
numbers of patients. The finding of intracellular 
CPPD crystals in chondrocytes in this single 
patient study points to the existence of an intra- 
cellular pathway of CPPD crystal formation in 
CPPD crystal deposition disease of the TMJ and 
possibly in CPPD crystal deposition disease in 
general. 
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